Concourse Financial Group Securities’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 10629 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 10909 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 10819 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 10666 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 10688 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 10817 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 10859 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 10937 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 10557 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 10560 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 10375 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 10158 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 9915 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 9472 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 8801 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 8294 |
|